Last year it was all about the CVA; this year it could be all about the EMA (European Medicines Agency). Canary Wharf Group v EMA is already the most eagerly anticipated case of the year and commentators are suggesting that if the EMA wins, the outcome could have serious ramifications for landlords and the wider property industry as a whole.